Resistin and cardiovascular disorder

African Journal of Pharmacy and Pharmacology

Volumn 5, Issue 1, 2011, Pages 1-5

  Sharma, Ramica ^a   Kumar, Chetan ^a   Gangwani, Shaveta ^a   Sugga, Gurfateh Singh ^a   Rana, A C ^a  

^a Rayat Institute of Pharmacy   (India)

Author keywords

Adipokine; Cardiovascular disorders; Cysteine; Macrophages; Monocytes; Resistin

Indexed keywords

RESISTIN;

ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; DIABETES MELLITUS; HEART VENTRICLE HYPERTROPHY; HUMAN; HYPERTENSION; INFLAMMATORY DISEASE; METABOLIC SYNDROME X; NONHUMAN; PATHOGENESIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; RHEUMATIC DISEASE; SIGNAL TRANSDUCTION; UPREGULATION;

EID: 79952214503     PISSN: None     EISSN: 19960816     Source Type: Journal    
DOI: None     Document Type: Review

References (40)

1. Kader NA, Ali El-Din FA, Khatab EAA, Elabd NEE (2010). Does plasma resistin level have a role in predicting inflammatory bowel disease activity, Indian J Gastroentrol DOI: 10.1007/s12664-010-0008-1.
2. Aquilantea CL, Kosmiskib LA, Knutsena SD, Zinehc I (2008) Relationship between plasma resistin concentrations, inflammatory chemokines, and components of the metabolic syndrome in adults. Metab. Clin. Experimental., 57: 494-501.
3. Barnes KM, Miner JL (2009). Role of Resistin in Insulin Sensitivity in Rodents and Humans. Curr. Prot. Peptide. Sci., 10: 96-107.
4. Bokarewa M, Nagaev I, Dahlberg L, Smith U, Tarkowski A (2005). Resistin, an adipokine with potent proinflammatory properties. J. Immunol., 174: 5789-5795.
5. Burnett MS, Lee CW, Kinnaird TD, Stabile E, Durrani S, Dullum MK, Devaney JM, Fishman C, Stamou S, Canos D, Zbinden S, Clavijo LC, Jang GJ, Andrews JA, Zhu J, Epstein SE (2005). The potential role of resistin in atherogenesis. Atherosclerosis, 182: 241-248.
6. Calabro P, Samudio I, Willerson JT, Yeh ET (2004). Resistin promotes smooth muscle cell proliferation through activation of extracellular signal regulated kinase 1/2 and phosphatidylinositol 3-kinase pathways. Circulation, 110: 3335-3340.
7. Chen C, Jiang J, Lü JM, Chai H, Wang X, Lin PH, Yao Q (2010) Resistin decreases expression of endothelial nitric oxide synthase through oxidative stress in human coronary artery endothelial cells. Am. J. Physiol. Heart. Circ. Physiol., 299: 193-H201.
8. Choi HM, Lee YA, Lee SH, Hong SJ, Hahm DH, Choi SY, Yang HI, Yoo MC, Kim YS (2009). Adiponectin may contribute to synovitis and joint destruction in rheumatoid arthritis by stimulating vascular endothelial growth factor, matrix metalloproteinase-1, and matrix metalloproteinase-13 expression in fibroblast-like synoviocytes more than proinflammatory mediators. Arthr. Res. Ther., 11: 161.
9. Cohen G, Hörl WH (2009). Resistin as a cardiovascular and atherosclerotic risk factor and uremic toxin. Semin. Dial., 22: 373-377.
10. Dimitriadis K, Tsioufis C, Selima M, Tsiachris D, Miliou A, Kasiakogias A, Andrikou E, Tousoulis D, Stefanadis C (2009). Independent association of circulating resistin with glomerular filtration rate in the early stages of essential hypertension. J. Hum. Hyper., 23: 668-673.
11. Fargnoli JL, Sun Qi, Olenczuk D, Qi Lu, Zhu Y, Hu FB, Mantzoros SC (2010). Resistin is associated with biomarkers of inflammation while total and high-molecular weight adiponectin are associated with biomarkers of inflammation, insulin resistance, and endothelial function. Eur. J. Endocrinol., 162: 281-288.
12. Grant EP, Picarella D, Burwell T, Delaney T, Croci A, Avitahl N, Humbles AA, Gutierrez-Ramos JC, Briskin M, Gerard C, Coyle AJ (2002). Essential role for the C5a receptor in regulating the effector phase of synovial infiltration and joint destruction in experiment alarthritis. J. Exp. Med., 196: 1461-1471.
13. Gomez-Ambrosi J, Fruhbeck G (2005). Evidence for the Involvement of Resistin in Inflammation and Cardiovascular Disease. Cur.t Dia. Rev., 1:227-234.
14. Jung HS, Park KH, Cho YM, Chung SS, Cho HJ, Cho SY, Kim SJ, Kim SY, Lee HK, Park KS (2006). Resistin is secreted from macrophages in atheromas and promotes atherosclerosis. Cardiovasc. Res., 69: 76-85.
15. Karmiris K, Koutroubakis IE, Kouroumalis EA (2005).The Emerging Role of Adipocytokines as Inflammatory Mediators in Inflammatory Bowel Disease. Inflamm Bowel. Dis., 11: 847-855.
16. Karmiris K, Koutroubakis IE (2007). Resis tin: another rising biomarker in inflammatory bowel disease, Eur. J.Gastroenterol. Hepatol., 19: 1035-1037
17. Kaser S, Kaser A, Sandhofer A, Ebenbichler CF, Tilg H, Patsch JR (2003). Resistin messenger-RNA expression is increased by proinflammatory cytokines in vitro. Biochem. Biophys. Res. Commun., 309: 286-290.
18. Kawanami D, Maemura K, Takeda N, Harada T, Nojiri T, Imai Y, Manabe I, Utsunomiya K, Nagai RM (2004). Direct reciprocal effects of resistin and adiponectin on vascular endothelial cells: a new insight into adipocytokine- endothelial cell interactions. Biochem. Biophys. Res. Commun., 314: 415-419.
19. Kim M, Oh JK, Sakata S, Liang L, Park W, Hajjar RJ, Lebeche D (2008) Role of Resistin in Cardiac Contractility and Hypertrophy. J. Mol. Cell. Cardiol., 45: 270-280.
20. Kougias P, Chai H, Lin PH, Lumsden AB, Yao Q, Chen C (2005). Adipocyte-derived cytokine resistin causes endothelial dysfunction of porcine coronary arteries. J. Vasc. Surg., 41: 691-698.
21. Kunnari A, Ukkola O, Paivansalo M, Antero Kesanidmi Y (2006). High Plasma Resistin Level Is Associated with Enhanced Highly Sensitive C-Reactive Protein and Leukocytes. J. Clin. Endocrinol. Metab., 91: 2755-2760.
22. Kusminski CM, Mcternan PG, Kumar S (2005). Role of resistin in obesity, insulin resistance and Type II diabetes. Clin. Sci., 109: 243-256
23. Lee TS, Lin CY, Tsai JY, Wu YL, Su KH, Lu KY, Hsiao SH, Pan CC, Kou YR, Hsu YP, Ho LT (2009). Resistin increases lipid accumulation by affecting class A scavenger receptor, CD36 and ATP-binding cassette transporter-A1 in macrophages. Life. Sci., 16: 97-104.
24. Lu SC, Shieh WY, Chen CY, Hsu SC, Chen HL (2002). Lipopolysaccharide increases resistin gene expression in vivo and in vitro. FEBS. Lett., 530: 158-162.
25. Migita K, Maeda Y, Miyashita T, Kimura H, Nakamura M, Ishibashi H, Eguchi K (2006). The serum levels of resistin in rheumatoid arthritis patients. Clin. Exp. Rheumatol., 24: 698-701.
26. Mule G, Cottone S (2010). Resistin: A New Marker of Cardiorenal Risk, Am. J. Hypertens., 23: 585.
27. Nogueiras R, Gualillo O, Caminos JE, Casanueva FF, Dieguez C (2003). Regulation of resistin by gonadal, thyroid hormone, and nutritional status. Obes. Res., 11: 408-414.
28. Norata GD, Ongari M, Garlaschelli K, Raselli S, Grigore L, Catapano AL (2007). Plasma resistin levels correlate with determinants of the metabolic syndrome. Eur. J. Endocrinol. 156: 279-284.
29. Patel L, Buckels AC, Kinghorn IJ, Murdock PR, Holbrook JD, Plumpton C, Macphee CH, Smith SA (2003). Resistin is expressed in human macrophages and directly regulated by PPARα activators. Biochem. Biophys. Res. Commun., 300: 472-476.
30. Rajala MW, Obici S, Scherer PE, Rossetti L (2003). Adipose-derived resistin and gut-derived resistin-like molecule-beta selectively impair insulin action on glucose production. J. Clin. Invest., 111: 225-230.
31. Reilly MP, Lehrke M, Wolfe ML, Rohatgi A, Lazar MA, Rader DJ (2005) Resistin Is an Inflammatory Marker of Atherosclerosis in Humans. Circulation 111; 932-939.
32. Rizkalla J, Melone M, Zhao A, Rashid S (2009). The Pathophysiological Role of resistin in Impaired Lipoprotein Metabolism in Obesity. Circulation 120: S529.
33. Steppan CM, Wang J, Whiteman EL, Birnbaum MJ, Lazar MA (2005). Activation of SOCS-3 by resistin. Mol. Cell. Biol., 25: 1569-1575
34. Stofkova A (2010). Resistin and Visfatin: Regulators of insulin sensitivity, inflammation and immunity. Endocrine Regulations. 44: 25-36.
35. Tuttolomondo A, Placa SL, Domenico Di Raimondo DD, Bellia C, Antonietta Caruso A, Sasso BL, Giovanni Guercio G, Giuseppe Diana G, Ciaccio M, Licata G, Pinto A (2010). Adiponectin, resistin and IL-6 plasma levels in subjects with diabetic foot and possible correlations with clinical variables and cardiovascular co-morbidity. Diabetol., 9: 50.
36. Ukkola O (2002). Resistin-a mediator of obesity-associated insulin resistance or an innocent bystander? Eur. J. Endocrinol., 147: 571-574.
37. Verma S, Li SH, Wang CH, Fedak PWM, Li RK, Weisel RD, Mickle AG (2003). Resistin promotes endothelial cell activation: further evidence of adipokine endothelial interaction. Circulation, 108: 736-740.
38. Xu W, Yu L, Zhou W, Luo M (2006). Resistin increases lipid accumulation and CD36 expression in human macrophages. Biochem. Biophys. Res. Commun., 351: 376-382.
39. Zhang L, Curhan GC, Forman JP (2010). Plasma Resistin Levels Associate with Risk for Hypertension among Nondiabetic Women. J. Am. Soc. Nephrol., doi:10.1681/ASN.2009101053.
40. Zhang Z, Xing X, Hensley G, Chang LW, Liao W, Abu-Amer Y, Sandell LJ (2010). Resistin induces expression of proinflammatory cytokines and chemokines in human articular chondrocytes via transcription and messenger RNA stabilization. Arthritis, Rheumatism., 62: 1993-2003.